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Abstract
Background—The objective of this study was to validate previously published rates of 
remission, continuation, and incidence of broadly defined eating disorders during pregnancy. The 
previous rate modeling was done by our group (Bulik et al. 2007) and yielded participants halfway 
into recruitment of the planned 100,000 pregnancies in the Norwegian Mother and Child (MoBa) 
Cohort at the Norwegian Institute of Public Health. This study aimed to internally validate the 
findings with the completed cohort.
Methods—77267 pregnant women enrolled at 17 weeks gestation between 2001 and 2009 were 
included. Participants were split into a “training” sample (n=41243) based on participants in the 
MoBa version 2 dataset of the original study and a “validation” sample (n=36024) comprising 
individuals in the MoBa version 5 dataset that were not in the original study (Bulik et al. 2007). 
Internal validation of all original rate models involved fitting a calibration model to compare 
model parameters between the “training” and “validation” samples as well as bootstrap estimates 
of bias in the entire version 5 dataset.
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Results—Remission, continuation, and incidence estimates from the “training” sample remained 
stable when evaluated via a split sample validation procedure. Pre-pregnancy prevalence estimates 
in the “validation” sample were 0.1% for anorexia nervosa, 1.0% for bulimia nervosa (BN), 3.3% 
for binge eating disorder (BED), and 0.1% for purging disorder (EDNOS-P). In early pregnancy, 
estimates were 0.2% for BN, 4.8% for BED, and <0.01% for EDNOS-P. Consistent with the 
original study, incident BN and EDNOS-P during pregnancy were rare. For BED, the adjusted 
incidence rate in the “validation” sample was 1.17 per 1000 person-weeks. The highest rates were 
for full or partial remission for BN and EDNOS-P, and continuation for BED.
Conclusions—This study provides evidence of validity of previously estimated rates of 
remission, continuation, and incidence of eating disorders during pregnancy. Eating disorders 
during pregnancy were relatively common, occurring in nearly 1 in every 20 women, although 
almost all were cases of BED. Pregnancy was a window of remission from BN but a window of 
vulnerability for onset and continuation of BED. Training to detect the signs and symptoms of 
eating disorders by obstetricians/gynecologists and interventions to enhance pregnancy and 
neonatal outcomes warrant attention.
Keywords
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Mother and Child Cohort Study
Introduction
Eating disorders in pregnancy are poorly understood but warrant attention. Epidemiological 
data from our group suggest, first, that eating disorders during pregnancy are reasonably 
common, with prevalence estimates ranging between 0.1% (purging disorder, EDNOS-P) to 
4.8% (binge eating disorder, BED) (Bulik et al. 2007). Second, pregnancy is a high-risk 
period for onset of BED, occurring at a rate of 1.1 per 1000 person-weeks (Bulik et al. 
2007). Eating disorder symptoms during pregnancy are more prevalent among those with a 
recent or past history of eating disorders (Micali et al. 2007b). Over a quarter of pregnant 
women with eating disorders purge and 11% report dieting for weight loss at 32 weeks 
(Micali et al. 2007b). Offspring of women with eating disorders are at higher risk for birth 
complications including perinatal mortality, premature birth, low birth weight, and birth 
defects (Bulik et al. 1999, Micali et al. 2007a, Sollid et al. 2004). Persistence of eating 
disorders beyond pregnancy may increase child vulnerability through risk factors associated 
with the expression of illness. Mothers with and without eating disorders self-report 
different feeding styles, with restrictive feeding styles and infant feeding problems more 
common among mothers with eating disorders characterized by binge eating (Reba-
Harrelson et al. 2010). Indeed, mothers with eating disorders express concern about knowing 
how to feed their children appropriately (Mazzeo et al. 2005). Positively, pregnancy appears 
to be a “window” for remission of bulimia nervosa (BN) (Bulik et al. 2007). Recognition of 
eating disorders before and during pregnancy is a necessary first step to engaging 
individuals in treatment and parenting-based interventions to improve eating disorder and 
obstetric outcomes and promote healthy child development.
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Research on the course of eating disorders through pregnancy originated in the 1980s and 
has typically used retrospective reports or small prospective samples with clinical or at-risk 
participants (e.g., Blais et al. 2000, Crow et al. 2004, Koubaa et al. 2005, Lacey and Smith 
1987, Rocco et al. 2005, Tiller and Treasure 1998). Although valuable clinical data had 
accumulated, an epidemiological perspective on the prevalence and course of eating 
disorders through pregnancy was absent, meaning there were no reliable estimates of the 
percentage of women who experience, develop, or remit from eating disorders during 
pregnancy, which is essential to guide research, health planning, and service provision.
To address this, we (Bulik et al. 2007) examined data from an ongoing prospective 
population-based pregnancy cohort study, which was approximately halfway toward the 
goal of recruiting 100000 pregnancies, the Norwegian Mother and Child Cohort Study 
(MoBa; Magnus et al. 2006). We provided estimates of eating disorder prevalence pre-
pregnancy, and rates of incidence, continuation, and remission of eating disorders during 
pregnancy. Eating disorders, either new or continuing, were common. Six months prior to 
pregnancy, the prevalence was 0.1% for anorexia nervosa (AN), 0.7% for BN, 3.5% for 
BED, and 0.1% for EDNOS-P. During pregnancy, estimates were 0.2% (BN), 4.8% (BED), 
and 0.1% (EDNOS-P). A prominent and somewhat unexpected finding was the relatively 
high prevalence of BED onset (1.7%) which was more probable among women with lifetime 
and psychosocial adversities (Berg et al. 2011). Full or partial remission during pregnancy 
was the most common course for BN and EDNOS-P, but BED had a high continuance rate.
The findings of the study by our group (Bulik et al. 2007) are significant, yet unconfirmed, 
due primarily to methodological practicalities that impede progress in the external validation 
of these findings; notably, the need for a large population sample to ensure adequate 
statistical power. The first reason why it is important to replicate prevalence and course 
estimates is that it would be damaging to the community if health planning and policy was 
misaligned with community need on the basis of unreproducible scientific evidence, and 
ultimately disparaging to academic enterprise. Second, given the absence of widespread data 
on the prevalence of eating disorders in pregnancy, all large-scale field data at present have 
substantial implications for health research.
Hence, the purpose of this study was to internally validate the statistical modeling of 
incidence, remission and continuation used in the first study. Furthermore, it is important to 
note that validation of modeling is distinct from other types of validation such as validation 
of a data collection instrument. Internal validation of a statistical model entails an 
assessment of the ability of a certain model to accurately predict outcomes. In this particular 
case, we evaluate the performance of models predicting rates of incidence, remission and 
incidence across eating disorder subtypes.
We hypothesized that the models would internally validate given evidence of the stability of 
eating disorder prevalence in Norway (Zachrisson et al. 2008). Given the context, we chose 
a split sample approach with model recalibration to determine if observed estimates in the 
latter half of the sample were similar to predicted estimates. Outcomes from this analysis 
can provide evidence towards reproducibility of the original model and its findings – a 
critical yet rare process (Altman et al. 2009). At the time of publication of the original 
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estimates (Bulik et al. 2007), data collection from the cohort sample was incomplete. The 
MoBa goal of recruitment of more than 100000 pregnancies (recruited from 1999 to 2009) is 
now completed enabling us to conduct a statistical approach to validation.
Method
Participants
This study is nested within the MoBa study, which is conducted by the Norwegian Institute 
of Public Health (Magnus et al. 2006). The total sample comprised 77267 pregnant women 
with valid MoBa data (version 5, release May 2010). Participants were split into a “training” 
sample (n=41243) based on participants in the MoBa version 2 dataset (released April 2006) 
of the original study and a “validation” sample (n=36024) comprising individuals in the 
MoBa version 5 dataset who were not in the original study (Bulik et al. 2007) (Fig. 1). The 
total sample is less than the overall MoBa cohort as inclusion criteria (below) were 
necessary to enhance internal validity; participant flow is depicted in Figure 1. The split 
approximately halved the cohort across time creating in essence a temporal validation. It 
should also be noted that the “training” sample and the “validation” sample are recruited 
from overlapping but to some extent different parts of the total population of Norway.
The Medical Birth Registry of Norway (MBRN) monitors trends in birth and administrates a 
complete nationwide registry with consecutive registration of all births with gestational age 
> 16 weeks since 1967; notification of births to MBRN is compulsory for physicians and 
midwives. MoBa is a nationwide prospective population-based pregnancy cohort study that 
recruited pregnant women via postal invitation before an ultrasound appointment in week 
17–18 of pregnancy in Norway between 1999 to 2009 (Magnus et al. 2006), and 38.5% of 
invited women consented to participate (http://www.fhi.no/moba-en). The cohort now 
includes 108000 children, 90700 mothers and 71500 fathers. Approval for this research was 
granted by appropriate regional committees, the Norwegian Data Inspectorate, and the 
Institutional Review Board of the University of North Carolina at Chapel Hill.
Inclusion criteria for this study were women with a first pregnancy during the study period, 
singleton birth, and live birth. Exclusion criteria were a missing pregnancy ID precluding 
data linking, completion of the pilot version of the questionnaire, weight <30 or >300 kg 
before and during pregnancy, height <1 m, women who returned the MoBa survey after 
birth, missing responses precluding assessment of eating disorder caseness, and a missing 
age value.
Measures
The Norwegian Mother and Child Cohort Study (MoBa) Questionnaire 1 [http://
www.fhi.no/dokumenter/1f32a49514.pdf] contained items on eating disorders and behaviors 
that were previously used for studies of eating disorders in the Norwegian Institute of Public 
Health Twin Panel (Harris et al. 2002, Reichborn-Kjennerud et al. 2003, Reichborn-
Kjennerud et al. 2004a, Reichborn-Kjennerud et al. 2004b). Items were designed to 
operationalize DSM-IV criteria for AN, BN, and eating disorders not otherwise specified 
(American Psychiatric Association 1994). Questions for binge eating addressed eating an 
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unusually large amount of food with an accompanying sense of loss of control and 
respondents were instructed to distinguish between pregnancy-related nausea and vomiting 
and self-induced vomiting as a compensatory method. Respondents included in this study 
completed questionnaire 1 at a median of 17.1 weeks gestation (inter-quartile range 15.9–
18.9 weeks and range 4.0–42.1 weeks).
Eating disorder classifications—Algorithms in the original study (Bulik et al. 2007) 
constructed from Questionnaire 1 items were used to define eating disorder diagnoses: 
broadly defined AN, defined as meeting DSM-IV criteria for AN (with the exception of 
amenorrhea and also endorsing a body mass index (BMI) < 19.0 kg/m2 at the time of low 
weight); broadly defined BN (endorsing at least weekly frequency of binge eating and 
purging and categorized as BN any type, BN purging type, BN non-purging type); broadly 
defined BED (binge eating at least weekly in the absence of compensatory behaviors); and 
EDNOS-P (purging at least weekly in the absence of binge eating). Due to practical 
difficulties in determining low weight in the presence of pregnancy-related weight gain, AN 
was assessed prior to pregnancy only. BN, BED, and EDNOS-P were assessed for both six 
months prior to pregnancy (retrospective assessment) and at the time of survey completion. 
Self-reported weight and height were used to calculate pre-pregnancy BMI and BMI at the 
time of assessment.
Diagnostic classifications pre-pregnancy comprised the categories of AN, BN purging type, 
BN non-purging type, BN any type, BED, EDNOS-P, and “missing”. These classifications 
were also applied during pregnancy, with the exception of AN due to the difficulties noted 
earlier.
If an individual had a missing response on one criterion but scored positively on all other 
criteria for a diagnosis, a classification of missing was assigned, otherwise no eating 
disorder was indicated. The BN any type includes BN purging and non-purging types as 
well as an additional category of people; this category was assigned when individuals met 
criteria for BN including endorsing non-purging compensatory behaviors (i.e., fasting and 
exercise) but had missing values for the purging items (i.e., laxatives and self-induced 
vomiting).
Definition of remission, incidence, and continuation—Remission described 
individuals who experienced an eating disorder pre-pregnancy and had no eating disorder 
during pregnancy. For BN, remission described an absence of both binge eating and 
compensatory behaviors during pregnancy. Partial remission pertained to individuals with 
BN pre-pregnancy who reported ongoing binge eating but the absence of compensatory 
behaviors during pregnancy. Continuation described individuals who presented with the 
same eating disorder pre- and during pregnancy. Incidence referred to onset of a broadly 
defined eating disorder when none was present in the six months prior to pregnancy.
Statistical analysis
We used two different methods to internally validate the statistical models used in the 
original analysis. The first method is model calibration, which provides information 
regarding accuracy of the predicted rates from the “training” sample. The second method is 
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the bootstrap estimate of bias, which indicates whether estimates from the entire version 5 
dataset differ from the true population estimates. Given that the MoBa dataset does not 
include the entire population of Norwegian pregnancies between 1999 and 2009, estimate 
bias in the models is possible. In the original study (Bulik et al. 2007) regression models 
estimated rates of eating disorder remission, continuation, and incidence during pregnancy 
by diagnosis type, also, measures of association between sociodemographic measures and 
BED incidence were defined and discussed.
The split samples were used to calculate calibration statistics (Steyerberg 2009, Steyerberg 
et al. 2004). The calibration method is a multi-step procedure estimating the degree to which 
parameter estimates from a “training” sample predict observed values in the “validation” 
sample. Regression coefficients are first estimated using the original models with the 
“training” data. Next, a linear combination of those coefficients and any relevant covariables 
from the “validation” dataset — the linear predictor — comprise the only covariate in the 
final calibration model with response values from the “validation” dataset. Considering the 
specification of generalized linear regression models, an offset is also used with the linear 
predictor. For an intercept-only calibration, the updated alpha (α:intercept) should 
approximate zero in the final model thus providing evidence that the outcome value as 
predicted by the “training” sample is no different from the observed response value from the 
“validation” sample. For measures of rates, the α:intercept is reported for unadjusted results. 
Age-adjusted results in the original paper are a product of combinations of model 
coefficients and not eligible for the calibration procedure. For measures of association 
between sociodemographic variables and outcomes βoverall is reported, which ideally should 
approximate one in the final model. The unreliability [U]-statistic and Brier score, as 
described in Steyerberg (2004), indicate a measure of the overall model performance and 
miscalibration, respectively, in the context of the split sample validation design. The Brier 
score and U-statistic approximate zero if updated estimates provide good fit. Simulations 
prior to calibration determined that a sample size of at least 500 was required to obtain at 
least 80% power to detect a 20% difference in rates from models using the proposed 
validation method (i.e., calibration α statistically significantly different from zero). BED is 
the only eating disorder that meets this sample size criterion thus any failure to find a 
difference would be worthwhile noting for this particular eating disorder only.
A final measure of internal validity, the bootstrap estimate of bias (Efron and Tibshirani 
1993, Good 2006), was applied to estimated rates for all eating disorder subtypes. The 
bootstrap sampling method generates samples with replacement from the original sample. 
We generated 1000 bootstrap samples and obtained model parameters from each sample. 
Rate estimates across the 1000 samples were averaged to obtain the mean, and the standard 
deviation of estimates was used to form the 95% confidence intervals (CIs) of the 
bootstrapped mean estimate. Estimate bias calculations are described; these are the original 
estimated mean in the observed sample subtracted from the bootstrap mean. A positive bias 
indicates the original estimate is under-estimating the true population value, conversely, a 
negative estimate indicates over-estimation of the parameter. Bias much greater than the 
standard error of the estimated mean may indicate poor estimation (Efron and Tibshirani 
1993).
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It should be noted that the models for EDNOS-P did not converge in more than 60% of the 
samples for the continuation and remission rates because of sparse cell counts. Incidence 
models frequently did not converge for BN purging and BN non-purging groups (68% and 
38%, respectively). It should be noted that lack of convergence in this situation leaves at 
most 62% of the replications to form the estimated rates in the bootstrap estimate for those 
groups. The lack of convergence precluded any specification for the aforementioned 
combination of outcomes and groups in estimates presented in Table 6.
Data analysis was based on version 5 of the quality-assured MoBa data file released for 
research in 2010. The number of respondents in the “training” sample from MoBa version 5 
dataset does not identically match those from the original version 2 dataset (Bulik et al. 
2007). There were >1900 pregnancy identification numbers not linked to a unique maternal 
identification number in the version 2 dataset precluding identification of singleton births for 




Table 1 presents the sociodemographic composition of the “training” and “validation” 
samples. The “validation” sample appears to represent a more advantaged group with close 
to 10 point higher proportions with >4 years of university education and the two highest 
income thresholds, and had elevated primiparity (64.4% versus 48.1%) and cohabitation 
(54.5% versus 47.4%).
Eating disorder prevalence
The prevalence of eating disorders before and during pregnancy, and frequencies of 
remission, incidence, and continuation are shown in Table 2. In the 6 months before 
pregnancy, the prevalence ranged from 0.1% for AN to 3.5% for broad BED across both the 
“training” and “validation” samples. In both samples, the most common course of illness 
was continuation for BED (training: 62%, validation: 60%, total (data not shown): 61%), 
remission and/or partial remission for BN (training: 69%, validation: 78%, total: 74%), and 
remission for EDNOS-P (training: 79%, validation: 80%, total: 79%). Eating disorders 
during pregnancy were relatively common (occurring in 1 in every 21 women), though these 
were mainly made up of BED (1 in 23 women).
Remission, continuation, and incidence
Table 3 shows age-adjusted rates of remission, incidence, and continuation, by sample 
across eating disorder subtypes. The remission rate was highest for EDNOS-P, followed by 
BED broad, and BN in both the “training” and “validation” samples. The incidence rate was 
highest for broad BED, at 1.22 (95% CI=1.14–1.31) and 1.17 (95% CI=1.09–1.27) per 1000 
person-weeks for the “training” and “validation” samples, respectively.
Watson et al. Page 7























The validation analysis quantified differences between the split samples by comparing the 
observed rates in the “validation” sample with the predicted rates from the “training” sample 
(Table 4). A positive alpha estimate in the calibration model indicates that the observed rate 
in the “validation” sample is higher than the predicted rate from the “training” sample. For 
example, the alpha for BED remission is 0.04 (95% CI=−0.03–0.12) indicating the observed 
rate in the “validation” sample is 4 percent higher than the rate in the “training” sample. 
According to the calibration estimates for BED (see Table 4), the “validation” sample had 
higher rates of favorable outcomes (remission) and lower rates of unfavorable outcomes 
(continuation and incidence) relative to the “training” sample. The effects were mixed for 
BN (lower continuation rates and higher incidence in the “validation” sample) and opposite 
effects were observed for EDNOS-P. All CIs spanned zero, with one exception for BN 
continuation, thus inferring no statistically significant differences in predicted and observed 
rates. Brier scores and U-statistics were close to zero, indicating good model performance. 
Overall, the rate models were well-calibrated and internally valid, as hypothesized (see 
Table 4).
Characteristics associated with incidence
Exploratory analysis in the original paper (Bulik et al. 2007) included measures of 
association between sociodemographic predictors and BED incidence. These measures were 
estimated for the “training” and “validation” samples and the differences between those 
estimates quantified (Table 5). The differences are not inconsequential as they exceed a 20% 
difference in the “validation” versus the “training” sample for half of the predictors 
including ‘ever smoke?’ (21% higher), ‘infertility treatment’ (34% lower), ‘minimum 
combined income’ (38% lower), and ‘total live births’ (60% lower). All 95% CIs for the 
βoverall estimate span one discounting any evidence that estimates from the “validation” 
sample differ from the “training” sample; there is one exception, which is “total live births”. 
The “validation” sample indicates a 60% lower estimated association (βoverall=0.40, 95% 
CI=−0.06–0.85) with incidence in the “validation” sample than predictions based on the 
“training” sample. In the “validation” sample the estimates indicate lower incidence for the 
nulliparous relative to women with 2+ live births, and the strength of that association is 
about half that of the “training” sample (−0.23 v. −0.41).
Bias estimates of rates from sample
The bootstrap age-adjusted estimates of remission, continuation, and incidence are shown in 
Table 6 with bias estimates (original estimated mean in the total dataset subtracted from the 
bootstrap mean). Negative bias suggests that the total MoBa cohort rate estimate is larger in 
the sample than a rate obtained from the entire population, and vice versa for positive bias 
estimates. Bias in almost all cases was negative. However, for some groups the standard 
errors were similar to the size of the bias indicating substantial variability and little evidence 
to distinguish from a bias estimate of zero. Some exceptions were for remission bias 
estimates indicating evidence for upward bias in the Moba cohort (i.e., overestimation), for 
BN purging (−0.29, se=0.09) for example. For continuation, mostly negative bias estimates 
exceed the standard error for BN any type (−0.10, se=0.08), BN purging (−0.28, se=0.10). 
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There is no evidence for substantial bias for any incidence estimates as the bias is <0.01 and 
standard errors exceed the estimated bias.
Discussion
Updating previously published models of remission, continuation, and incidence of eating 
disorders in pregnancy established by our group (Bulik et al. 2007) with a “validation” 
sample via a parsimonious calibration approach indicates validity of the original predictions. 
With only one exception, all observed rates in the “validation” sample did not differ from 
predicted rates in the “training” sample. This was consistent with our expectations, given 
evidence of stable prevalence of eating disorders in Norwegian adults (Zachrisson et al. 
2008). Of note is that in spite of changes to the characteristics of the cohort over time (e.g., 
socioeconomic status, primiparity, cohabitation), the basic findings of the original study 
were unchanged, providing evidence of generalizability. In estimates of bias, the story is 
mixed with consistent negative bias suggesting more extreme estimates in the MoBa cohort 
than what might be found in the population. However, variability around these estimates 
does not provide conclusive evidence supporting this result. Lastly, validation of the 
exploratory aims estimating associations between sociodemographic predictors and BED 
incidence did not reveal significant departure from original estimates, but did indicate a 
level of variability around those estimates.
While validation was the focus of this study, some general findings are worthy of 
discussion. The prevalence of broadly defined eating disorders during pregnancy in the 
“validation” sample was 4.7%, comparable to the prevalence estimate of 4.8% in the 
approximate first half of the MoBa cohort, as shown in the present and our previous study 
(Bulik et al. 2007). These are likely to underestimate the true population prevalence given 
that other poorly defined EDNOS presentations could not be captured by the self-report 
methodology. The observed prevalence in this study is higher than the 0.5% prevalence of 
self-reported history of eating disorders in a United Kingdom pregnancy cohort (N=12254) 
(Micali et al. 2007b) and the point prevalence of 3.8%–4.0% in the Norwegian adult female 
population (Götestam and Agras 1995, Zachrisson et al. 2008); the difference is probably 
explained by the lowering of binge/purge thresholds from ≤2 per week to ≤1 per week in the 
MoBa studies, the less strict weight criterion for AN in the MoBA studies, and the inclusion 
of AN and BN only and use of a single-item self-report in Micali et al. The lowered binge/
purge thresholds are commensurate with those proposed for DSM-5. The prevalence of 
eating disorders in this study, and eating disorder behaviors more generally among pregnant 
women is alarmingly high; previous research shows that binge eating occurs among 17%–
44%, self-induced vomiting for weight control in 1%–2%, and dieting in 3%–37% 
(Abraham et al. 1994, Fairburn and Welch 1990, Soares et al. 2009). The morbidity, 
heightened risk of birth complications, and negative neonatal outcomes associated with 
eating disorders (Bulik et al. 1999, Micali et al. 2007a, Sollid et al. 2004) make 
identification of eating pathology imperative.
Fewer than half of obstetricians/gynecologists (ob/gyn) assess eating disorder history, body 
image concerns, and eating disorder behaviors, despite assessing related constructs of body 
weight, BMI, exercise, and dietary practices (Leddy et al. 2009). Lack of training in 
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identification of signs and symptoms, a perception that assessment falls outside the scope of 
practice, and lack of awareness of the consequences of eating disorders in pregnancy may 
explain this (Leddy et al. 2009). Nevertheless, vigilance for potential signs and symptoms 
can be easily incorporated into routine ob/gyn practice, via screening questions posed to the 
individual and through assiduity to selected anthropometric, biochemical, dietary intake, and 
clinical data, such as reproductive history (Nickols-Richardson 2008).
Pregnancy appears to be a vulnerability window for onset of some eating disorders, 
consistent with the findings of our former study (Bulik et al. 2007) and case reports (Tiller 
and Treasure 1998). As found in Bulik et al., onset cases generally comprised BED, while 
BN and EDNOS-P onset were rare. Specific physical and psychological factors have a 
conjectured role in eating disorder onset during pregnancy (Knoph Berg et al. 2008, Tiller 
and Treasure 1998). For BED onset specifically, low maternal education, low combined 
income, a native language other than the official country language, lifetime adversities, 
anxiety and depression, low social support, and weight concerns, are putative vulnerability 
factors (Knoph Berg et al. 2011). Given that we are not well-informed about BED 
prevention BED and that pregnancy is a risk period for mental illnesses (e.g., depression), 
attention to broad mental health promoting mechanisms is advisable. Health care providers 
can help with social support, skills to manage stress, body image issues, and anxiety and 
depression. Moreover, given documented differences in nutrition during pregnancy in 
women with BED (Siega-Riz et al. 2008), nutritional counseling may play a valuable role in 
ensuring healthy balanced nutrition throughout pregnancy and the subsequent lactation 
period.
Seventy-four percent with BN pre-pregnancy met criteria for remission or partial remission 
in early pregnancy. Improvement in binge-purge behaviors during pregnancy has been noted 
elsewhere (Crow et al. 2004, Lacey and Smith 1987), along with a reduction in general 
health risk behaviors, such as alcohol, tobacco, and other drug use (Crow et al. 2004). 
Maternal desire for healthy fetal development appears to motivate behavioral change during 
pregnancy (Lemberg and Phillips 1989). Previous studies have suggested that cognitive 
symptoms of BN (i.e., body dissatisfaction, weight concern) remain problematic or worsen 
during pregnancy (Crow et al. 2004, Micali et al. 2007a), even in the context of decreasing 
binge-purge, restricting, and health risk behaviors (Crow et al. 2004, Lemberg and Phillips 
1989) and binge-purge symptoms may return after childbirth (Crow et al. 2008). Pregnancy 
potentially offers a window to neutralize barriers to help-seeking (e.g., shame, ambivalence 
about treatment) and enhance engagement in treatment.
This study has several limitations. First, low power to detect differences in outcomes for the 
BN and EDNOS-P groups is a significant limitation. However, given the dearth of data on 
course of eating disorders during pregnancy, a decision was made to report all relevant 
information. Second, diagnostic measures involved self-report rather than clinical diagnostic 
interview, a practical preclusion due to the size of the sample; additionally the measure has 
not been psychometrically validated, but is based on DSM criteria. Third, the diagnostic 
criteria do not correspond directly to DSM-IV and may in fact be closer to DSM-5. Fourth, 
the overall prevalence of broadly defined eating disorders is conservative, given that the 
assessment of AN during pregnancy is methodologically compromised due to inability to 
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assess the weight criterion, hence prevalence of AN during pregnancy did not contribute to 
the overall prevalence estimate. Further, EDNOS generally is a heterogeneous and poorly 
defined diagnostic category; although some broadly agreed presentations such as BED, 
EDNOS-P, and subthreshold AN and BN were captured within this study, it was not 
possible to capture undefined presentations with the self-report method; hence, the observed 
overall prevalence of eating disorders likely underestimates the true population prevalence. 
Fifth, there may be selection bias in the recruitment into MoBa. The prevalences of eating 
disorder and eating disorder subtypes may differ between MoBa participants and the general 
Norwegian pregnant population, potentially influencing remission, continuation, and 
incidence rates during pregnancy. Lastly, we make the assumption here that eating disorder 
rates remain the same over time and we have temporal validation, however, it could be the 
case that the validation models are spurious and there is a change over time paired with a 
bad model predictive ability; however, there is no way to confirm this.
The high prevalence of broadly defined eating disorders (primarily BED) among 1 in every 
21 pregnant women and association between maternal eating disorders and birth 
complications (Bulik et al. 1999, Micali et al. 2007a, Sollid et al. 2004) underscore the need 
for detection and treatment of eating disorders during pregnancy. Physicians, midwives, and 
health care professionals play an important role in optimizing maternal and birth outcomes, 
therefore knowledge of the potential serious consequences of eating disorders coupled with 
identification and management strategies is vital.
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Participant flow to achieve final analysis sample. MoBa, The Norwegian Mother and Child 
Cohort Study. *Extrapolated from the reported 38.5% participation rate [http://www.fhi.no]. 
**Criteria not mutually exclusive
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Table 1
Sociodemographic characteristics of women in the MoBa “training” and “validation” samples
Characteristic Training Sample (n=41243) Validation Sample (n=36024)
Maternal age (yrs), M (SD) 29.9 (4.6) 30.1 (4.7)
Number of previous live births, N (%)
 0 19823 (48.1) 23216 (64.4)
 1+ 13695 (33.2) 8744 (24.3)
 2+ 7725 (18.7) 4064 (11.3)
Marital status, N (%)
 Married 20173 (49.3) 14995 (41.9)
 Cohabiting 19399 (47.4) 19499 (54.5)
 Single 915 (2.2) 789 (2.2)
 Divorced/widowed 422 (1.0) 467 (1.3)
Education, N (%)
 < 3 yrs high school 3676 (9.4) 2129 (6.3)
 Vocational high school 5666 (14.5) 4045 (11.9)
 3-yr high school general studies, junior college 6554 (16.8) 4488 (13.2)
 Regional technical college/4-yr university degree 15924 (40.8) 13760 (40.4)
 University/technical college, >4 yrs 7217 (18.5) 9618 (28.3)
Combined minimum income, N (%)
 0–$36K (200000 NOK) 3898 (10.2) 2714 (8.1)
 >$36K (200000 NOK) 21696 (57.0) 13217 (39.4)
 >$89K (500000 NOK) 8208 (21.6) 10523 (31.3)
 >$125K (700000 NOK) 4275 (11.2) 7128 (21.2)
Ever smoked (yes), N (%) 20394 (49.6) 18081 (50.4)
Smoking during pregnancy (yes), N (%) 4429 (10.8) 2266 (6.3)
Ever drank alcohol (yes), N (%) 38924 (95.5) 34488 (96.6)
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Table 4
Recalibration estimates and performance statistics for the recalibrated rate models of remission, continuation, 
and incidence of eating disorders during pregnancy in a Norwegian population-based pregnancy cohort 
(MoBa)
Recalibration type estimate Performance statistics
Course α:intercept (95% CI) U-statistic Brier score
BED
 Remissiona 0.04 (−0.03 – 0.12) 0.000362 0.000028
 Continuation −0.04 (−0.09 – 0.01) 0.000547 0.000028
 Incidence −0.04 (−0.11 – 0.04) 0.000015 0.000028
BN
 Remissiona 0.11 (−0.03 – 0.26) 0.002441 0.000028
 Partial remissionb 0.13 (−0.03 – 0.28) 0.002924 0.000028
 Continuation −0.36 (−0.59 – −0.13) 0.014905 0.000028
 Incidence 0.14 (−0.29 – 0.56) 0.000006 0.000028
EDNOS-Pc
 Remissiona <0.01 (−0.19 - 0.19) 0.000000 0.000028
 Continuation 0.20 (−0.72 – 1.12) 0.002439 0.000028
 Incidence 0.14 (−0.74 – 1.01) 0.000001 0.000028
BED, binge eating disorder; BN, bulimia nervosa; EDNOS-P, eating disorder not otherwise specified-purging disorder.
a
Remission indicates rate of no eating disorder at time of survey completion during pregnancy.
b
Partial remission in BN indicates absence of compensatory behaviors during early pregnancy.
c
EDNOS-P and incidence calculations except for BED were not age-adjusted due to small sample size
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